Clinical Trial Update: Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 trial of temsirolimus for advanced liver cancer in patients with cirrhosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Liver Cancer | Phase 2 | Status: TERMINATED